OXYTOCIN INHIBITS PROLIFERATION OF HUMAN BREAST-CANCER CELL-LINES

被引：0
|
作者：
CASSONI, P [1 ]
SAPINO, A [1 ]
NEGRO, F [1 ]
BUSSOLATI, G [1 ]
机构：
[1] UNIV TURIN, DEPT BIOMED SCI & ONCOL, I-10126 TURIN, ITALY
来源：
VIRCHOWS ARCHIV | 1994年 / 425卷 / 05期
关键词：
OXYTOCIN; BREAST CANCER; CELL GROWTH;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
In this study we show that treatment of MDA-MB231 hormone-independent human breast cancer cells with oxytocin (OT) or with the OT analogue F314 induces significant growth inhibition together with a change in cell phenotype. In MCF7 and T47D human breast cancer cells, OT inhibits oestrogen-induced cell growth. In these same cells, OT administration significantly enhances the inhibitory effect of tamoxifen on cell proliferation. MDA-MB231, MCF7 and T47D cells all express mRNA specific for the OT receptor. These data suggest that it may be possible to inhibit breast cancer growth using OT and OT analogues.
引用
收藏
页码：467 / 472
页数：6
相关论文
共 50 条
  • [31] INDIRECT MECHANISM OF ESTRADIOL STIMULATION OF CELL-PROLIFERATION OF HUMAN-BREAST CANCER CELL-LINES
    LYKKESFELDT, AE
    BRIAND, P
    BRITISH JOURNAL OF CANCER, 1986, 53 (01) : 29 - 35
  • [32] GENERATION OF HUMAN ANTIBODY-SECRETORY CELL-LINES FROM LYMPHOCYTES OF BREAST-CANCER PATIENTS
    BRENNER, BG
    MARGOLESE, RG
    HYBRIDOMA, 1984, 3 (01): : 69 - 69
  • [33] AUTOLOGOUS AND HOMOLOGOUS IMMUNOFLUORESCENT ANTIBODY TO ESTABLISHED BREAST-CANCER CELL-LINES
    WISEMAN, C
    CAILLEAU, R
    OLIVE, M
    BLUMENSCHEIN, GR
    BOWEN, JM
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1980, 16 (07): : 629 - 633
  • [34] ESTROGEN-RECEPTOR DISTRIBUTION IN ENUCLEATED BREAST-CANCER CELL-LINES
    WELSHONS, WV
    CORMIER, EM
    WOLF, MF
    WILLIAMS, PO
    JORDAN, VC
    ENDOCRINOLOGY, 1988, 122 (06) : 2379 - 2386
  • [35] EFFECTS OF ESTROGEN AND ANTIESTROGEN ON THE MORPHOLOGY OF SENSITIVE BREAST-CANCER CELL-LINES
    ZIPPEL, HH
    HACKENBERG, R
    KLEIN, PJ
    HOLZEL, F
    SCHULZ, KD
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 332 - 332
  • [36] CHARACTERIZATION OF A H-3 GNRH METHOD FOR THE MEASUREMENT OF GNRH BINDING-SITES IN HUMAN BREAST-CANCER AND BREAST-CANCER CELL-LINES
    RESHKIN, SJ
    PEZZETTA, A
    ALBARANI, V
    SCHITTULLI, F
    PARADISO, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (02) : 371 - 375
  • [37] STEROID METABOLISM IN HUMAN BREAST-CANCER CELL LINES
    RAJU, U
    SKLAREW, RJ
    POST, J
    LEVITZ, M
    STEROIDS, 1978, 32 (05) : 669 - 680
  • [38] PRODUCTION OF HUMAN-HUMAN HYBRIDOMAS SECRETING MONOCLONAL-ANTIBODIES REACTIVE TO BREAST-CANCER CELL-LINES
    AIHARA, K
    YAMADA, K
    MURAKAMI, H
    NOMURA, Y
    OMURA, H
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY, 1988, 24 (09): : 959 - 962
  • [39] IMMUNOREACTIVE HEPATOCYTE GROWTH-FACTOR IS PRESENT IN TISSUE-EXTRACTS FROM HUMAN BREAST-CANCER BUT NOT IN CONDITIONED MEDIUM OF HUMAN BREAST-CANCER CELL-LINES
    YAMASHITA, J
    OGAWA, M
    BEPPU, T
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1993, 82 (02): : 249 - 252
  • [40] COMPARATIVE CHEMOSENSITIVITY PROFILES IN 3 HUMAN BREAST-CANCER CELL-LINES WITH THE ATP-CELL VIABILITY ASSAY
    KOECHLI, OR
    SEVIN, BU
    PERRAS, JP
    ANGIOLI, R
    UNTCH, M
    STEREN, A
    RAMACHANDRAN, C
    AVERETTE, HE
    ONCOLOGY, 1994, 51 (06) : 552 - 558
12345